Mats Jerkeman
11 – 20 of 135
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma
-
National e-library for standardized chemotherapy regimens
Fyhr, Ann Sofie LU ; Borell, Jonas LU
; Jerkeman, Mats
LU
and Ek, Åsa
LU
(2020)
In Acta Oncologica
59(9).
p.1079-1083
Mark
- Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL
- An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement
- Association between anthropometry and lifestyle factors and risk of B-cell lymphoma : An exposome-wide analysis
- Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk
- p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphoma
- 2019
- Adherence to the mediterranean diet and lymphoma risk in the european prospective investigation into cancer and nutrition
- Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B-cell lymphoma : a Swedish lymphoma register study
- Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma : A Nordic Lymphoma Epidemiology Group Study